274 filings
8-K
BAX
Baxter International Inc.
21 Mar 24
Entry into a Material Definitive Agreement
4:32pm
8-K
BAX
Baxter International Inc.
4 Mar 24
Regulation FD Disclosure
8:30am
8-K
BAX
Baxter International Inc.
8 Feb 24
Baxter Reports Fourth-quarter and Full-year 2023 Results
7:18am
8-K
BAX
Baxter International Inc.
2 Nov 23
Baxter Reports Third-quarter 2023 Results
7:18am
8-K
BAX
Baxter International Inc.
3 Oct 23
Baxter Appoints Joel Grade Chief Financial Officer
9:07am
8-K
ruct1jhna4ku
2 Oct 23
Completion of Acquisition or Disposition of Assets
9:02am
8-K
bwiszrsw x9v8u2
21 Aug 23
Baxter Announces Updates to Its Board of Directors
5:03pm
8-K
60oi6efyh
27 Jul 23
Baxter Reports Second-quarter 2023 Results
7:33am
8-K
czgiw
6 Jul 23
Regulation FD Disclosure
8:30am
8-K
3k5w1g6pr
29 Jun 23
Baxter Appoints William Ampofo to Its Board
4:18pm
8-K
lwvbks73
9 May 23
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to
8:42am
8-K
vmf5a
4 May 23
Submission of Matters to a Vote of Security Holders
4:45pm
8-K
r1scag9ikcl1
27 Apr 23
Baxter Reports First-quarter 2023 Results
7:18am
8-K
znpxb
13 Mar 23
Entry into a Material Definitive Agreement
4:45pm
8-K
uxmpvifler
14 Feb 23
Departure of Directors or Certain Officers
4:35pm
8-K
oy8nfx
9 Feb 23
Baxter Reports Fourth-quarter and Full-year 2022 Results
7:18am
8-K
r9zl5ijf 5w
6 Jan 23
Baxter Announces Strategic Actions to Enhance Operational Effectiveness, Accelerate Innovation for Patients and Drive Value for Shareholders
7:03am
8-K
4twum s7e
27 Oct 22
Baxter Reports Third-quarter 2022 Results
7:18am
8-K
u1cmeur
30 Sep 22
Entry into a Material Definitive Agreement
4:16pm
8-K
l6fg5nkqf9jpx5of4r
28 Jul 22
Baxter Reports Second-quarter 2022 Results
7:19am